Gemcitabine News and Research

RSS
Gemcitabine is the active ingredient in a drug that is used to treat pancreatic cancer that is advanced or has spread. It is also used together with other drugs to treat breast cancer that has spread, advanced ovarian cancer, and non-small cell lung cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Gemcitabine blocks the cell from making DNA and may kill cancer cells. It is a type of antimetabolite
In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Cocktail of chemotherapy drugs may be safe, effective for patients with metastatic pancreatic cancer

Cocktail of chemotherapy drugs may be safe, effective for patients with metastatic pancreatic cancer

New treatment may improve the quality of life for patients with mesothelioma

New treatment may improve the quality of life for patients with mesothelioma

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

Talazoparib did not show overall survival benefit in patients with advanced BRCA-mutated breast cancer

Talazoparib did not show overall survival benefit in patients with advanced BRCA-mutated breast cancer

Despite failures, chemotherapy still promising against fatal pediatric brain cancer

Despite failures, chemotherapy still promising against fatal pediatric brain cancer

Overview of prognostic and predictive factors in pancreatic cancer

Overview of prognostic and predictive factors in pancreatic cancer

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

Inexpensive drug may be used to counteract treatment resistance in patients with leukemia

Inexpensive drug may be used to counteract treatment resistance in patients with leukemia

Atlantic Health System Cancer Care enrolling patients in five pancreatic cancer studies

Atlantic Health System Cancer Care enrolling patients in five pancreatic cancer studies

Certain fungi increase pancreatic cancer risk, study finds

Certain fungi increase pancreatic cancer risk, study finds

Scientists identify pathway for treatment-resistant lung cancer

Scientists identify pathway for treatment-resistant lung cancer

Study opens a promising new front in the fight against pancreatic cancer

Study opens a promising new front in the fight against pancreatic cancer

New drug may enhance efficacy of chemotherapy in pancreatic cancer

New drug may enhance efficacy of chemotherapy in pancreatic cancer

The gift of longevity for a pancreatic cancer patient

The gift of longevity for a pancreatic cancer patient

Study shows synergistic effects of drugs that inhibit cell division in pancreatic cancer

Study shows synergistic effects of drugs that inhibit cell division in pancreatic cancer

Targeted pancreatic cancer drug shows promise in clinical trials

Targeted pancreatic cancer drug shows promise in clinical trials

New drug to treat pancreatic cancer shows promising results in clinical trial

New drug to treat pancreatic cancer shows promising results in clinical trial